Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. Company
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
Real-time Estimate Tradegate  -  05:34 2022-09-30 am EDT
49.51 EUR   +0.39%
09/21GERRESHEIMER AG : JP Morgan remains Neutral
MD
09/19Gerresheimer : Andrea Abt
PU
09/19Dd : Gerresheimer AG : Notification and public disclosure of transactions by persons
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Gerresheimer AG
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

Number of employees : 10 447 people.
Sales per Business
20202021Delta
Plastics & Devices765.1953.9%800.9553.5% +4.67%
Primary Packaging Glass644.1245.4%689.0946% +6.98%
Advanced Technologies9.480.7%7.970.5% -15.92%
EUR in Million
Sales per region
20202021Delta
Other Europe513.4036.2%560.4937.4% +9.17%
North America--417.0727.8%-
Germany317.8922.4%288.0619.2% -9.38%
Emerging Markets184.3913%194.6113% +5.54%
Other Regions21.781.5%37.792.5% +73.46%
EUR in Million
Managers
Name Title Age Since
Dietmar Siemssen Chief Executive Officer 59 2018
Bernd Metzner, Dr. Chief Financial Officer 51 2019
Jens KŘrten Group Senior Director-Communications & Marketing 52 2011
Cordula Niehuis, Dr. Senior Manager-Marketing - 2013
Lukas Burkhardt, Dr. Member-Management Board 43 2018
Members of the board
Name Title Age Since
Axel Herberg, Dr. Chairman-Supervisory Board 63 2015
Theodor Stuth Member-Supervisory Board 68 2008
Udo Johannes Vetter Member-Supervisory Board 67 2007
Karin Louise Dorrepaal, Dr. Member-Supervisory Board 59 2012
Peter Michael NoÚ, Dr. Member-Supervisory Board 64 2012
Andrea Abt Member-Supervisory Board 61 2015
Francesco Grioli Vice Chairman-Supervisory Board 50 2013
Markus Rocholz Member-Supervisory Board 51 2012
Katja M÷gel-Schnitzler Member-Supervisory Board 40 2016
Heike Arndt Member-Supervisory Board 58 2017
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 31,400,000 31,400,000 100.0% 0 0.0% 100.0%
Shareholders
NameEquities%
NN Investment Partners BV 4,005,837 12.8%
AllianceBernstein LP 1,821,042 5.80%
Schroder Investment Management Ltd. 1,526,289 4.86%
Massachusetts Financial Services Co. 1,090,308 3.47%
Norges Bank Investment Management 1,063,079 3.39%
Deka Investment GmbH 991,370 3.16%
Artisan Partners LP 981,297 3.13%
APG Asset Management NV 904,766 2.88%
The Vanguard Group, Inc. 895,469 2.85%
Threadneedle Asset Management Ltd. 737,571 2.35%
Company contact information
Gerresheimer AG
Klaus-Bungert-Strasse 4
Dusseldorf, Nordrhein-Westfalen 40468

Phone : +49.211.6181.00
Fax : +49.211.6181.295
Web : http://www.gerresheimer.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Gerresheimer AG
Sector Other Medical Equipment, Supplies & Distribution
1st jan.Capi. (M$)
GERRESHEIMER AG-41.77%1 513
ABBOTT LABORATORIES-30.16%172 880
MEDTRONIC PLC-20.47%109 775
BECTON, DICKINSON AND COMPANY-7.99%65 700
HOYA CORPORATION-19.61%34 187
DEXCOM, INC.-38.84%32 714
AMERISOURCEBERGEN CORPORATION2.39%28 687
BAXTER INTERNATIONAL INC.-35.58%27 981
SARTORIUS STEDIM BIOTECH-36.11%27 751
ZIMMER BIOMET HOLDINGS-13.95%22 562
TERUMO CORPORATION-16.05%21 316
FUJIFILM HOLDINGS CORPORATION-21.02%18 687
WEST PHARMACEUTICAL SERVICES, INC.-46.28%18 655
ALIGN TECHNOLOGY, INC.-67.89%16 567
INSULET CORPORATION-13.11%16 389
STERIS PLC-31.35%16 282
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.-8.96%14 664
AVANTOR, INC.-51.76%13 703
BIO-RAD LABORATORIES, INC.-44.65%12 681
SYSMEX CORPORATION-46.09%12 144
REPLIGEN CORPORATION-27.86%10 475